Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2026)
Dianthus Therapeutics (DNTH) reported Shares Outstanding of 37.79 million for Q4 2025, up 13.4% from 33.31 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2026) Analysis & Trends
Dating back to Q2 2017, Dianthus Therapeutics' Shares Outstanding record includes 35 quarters.
- Shares Outstanding has increased for eight consecutive years, with a five-year compound annual growth rate of 69.0% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 33.31 million in FY2024 (+546.4%), 5.15 million in FY2023 (+38.9%), 3.71 million in FY2022 (+8.1%) and 3.43 million in FY2021 (+25.1%).
- Year over year, Shares Outstanding has now increased in each of the last 27 quarters, with growth averaging 346.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 1.2% in Q3 2022 to 802.9% in Q2 2024.
- Per Business Quant data, the three quarters before Q4 2025 came in at 37.79 million (Q3 2025), 35.82 million (Q2 2025) and 35.79 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Dianthus Therapeutics | 5.00 Bn | 4.95 Bn | - | 57.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 57.34 Mn |
| Jun 30, 2026 | 56.03 Mn |
| Mar 31, 2026 | 48.03 Mn |
| Dec 31, 2025 | 37.79 Mn |
| Sep 30, 2025 | 37.79 Mn |
| Jun 30, 2025 | 35.82 Mn |
| Mar 31, 2025 | 35.79 Mn |
| Dec 31, 2024 | 33.31 Mn |
| Sep 30, 2024 | 34.24 Mn |
| Jun 30, 2024 | 34.23 Mn |
| Mar 31, 2024 | 25.67 Mn |
| Dec 31, 2023 | 5.15 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.71 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | 3.67 Mn |
| Dec 31, 2021 | 3.43 Mn |
API Access
Dianthus Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();